Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)
1 clinical trials · Condition
◉ Watch Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)
| Record | Firm | Date |
|---|---|---|
| Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL) (NCT00346684) | University of Cologne | 2006-07-01 |
Track Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD) automatically
Every clearance here is in the API, with alerts when new ones post.